25.7.2016 |
EN |
Official Journal of the European Union |
C 270/47 |
Action brought on 11 May 2016 — Hansen Medical v EUIPO — Covidien (MAGELLAN)
(Case T-222/16)
(2016/C 270/54)
Language in which the application was lodged: English
Parties
Applicant: Hansen Medical, Inc. (Mountain View, California, United States) (represented by: R. Kunze, Solicitor, G. Würtenberger, T. Wittmann, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Covidien AG (Neuhausen am Rheinfall, Switzerland)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: EU word mark ‘MAGELLAN’ – EU trade mark No 5 437 711
Procedure before EUIPO: Proceedings for a declaration of invalidity
Contested decision: Decision of the Second Board of Appeal of EUIPO of 3 February 2016 in Joined Cases R 3092/2014-2 and R 3118/2014-2
Form of order sought
The applicant claims that the Court should:
— |
annul the contested decision; |
— |
order EUIPO to pay the costs. |
Pleas in law
— |
Infringement of Articles 15, 51(1)(a), 57(1), 63(2), 64, 75, 76(2) and 77 of Regulation No 207/2009. |